http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
22nd Century VP of Regulatory Science to Present on Health Disparities Caused by Cigarette Addiction at FDLI Annual Conference
-
22nd Century Group Reports Business Highlights and Financial Results for the First Quarter 2021
-
22nd Century Group Installs State-of-the-Art Nicotine Testing Equipment to Enhance VLN® Production
-
22nd Century Group and KeyGene Extend and Expand Plant Research Partnership
-
22nd Century Group (XXII) Welcomes Ban on Menthol Cigarettes and Anticipates Further Standards as FDA Commissioner Reports Nicotine Cap on Combustibles "Still on the Table"
-
22nd Century Group Welcomes Ban on Menthol Cigarettes and Anticipates Further Standards as FDA Commissioner Reports Nicotine Cap on Combustibles “Still on the Table”
-
Congresswoman Gwen Moore Adds Voice to Groundswell of Support for Reducing Nicotine in Cigarettes, Encourages HHS Secretary Becerra to Take Action to Save Lives and End Health Disparities
-
22nd Century Delivers 3.6 Million Variable Nicotine Content Research Cigarettes for Independent Scientific Studies
-
22nd Century Group to Host Webcast to Discuss First Quarter 2021 Results
-
22nd Century Group (XXII) Issues Annual Letter to Shareholders
-
22nd Century Group Issues Annual Letter to Shareholders
-
22nd Century Group (XXII) Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S.
-
22nd Century Fully Prepared to Deliver the Solution as Biden Administration Considers Requirement to Lower Nicotine Level for All Cigarettes Sold in U.S.
-
22nd Century Stands Fully Prepared to Enable New Zealand Proposal to Advance Nationwide Smoke-Free Action Plan
-
22nd Century Group Regulatory Science VP Joins FDLI Tobacco and Nicotine Products Committee
-
Multiple Former FDA Commissioners Voice Support for Reduced Nicotine Mandate; Proposed Legislation Would Be Game-Changing for 22nd Century
-
Becerra Confirmation Boosts 22nd Century’s Position to Disrupt Tobacco Industry
-
22nd Century Group Receives Additional $3.7 Million from Cash Exercise of Outstanding Warrants
-
22nd Century Group Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2020
-
22nd Century Group to Participate in Investor Conferences in March 2021
-
22nd Century Group (XXII) Receives $8.1 Million from Cash Exercise of Outstanding Warrants
-
22nd Century Group Receives $8.1 Million from Cash Exercise of Outstanding Warrants
-
22nd Century Group (XXII) Secures Exclusive Agreement with CannaMetrix to Accelerate Commercialization of New, Disruptive Hemp/Cannabis Plant Lines and Intellectual Property
-
22nd Century Group Secures Exclusive Agreement with CannaMetrix to Accelerate Commercialization of New, Disruptive Hemp/Cannabis Plant Lines and Intellectual Property
-
22nd Century Group to Host Webcast to Discuss Fourth Quarter and Full-Year 2020 Results
-
22nd Century Group (XXII) Provides Business Update Letter from CEO
-
22nd Century Group Provides Business Update Letter from CEO
-
22nd Century Group (XXII) and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with Commercially Valuable Traits
-
22nd Century Group and KeyGene Launch Advanced Cannabis Technology Platform for Accelerated Development of New Varieties of Hemp/Cannabis Plants with Commercially Valuable Traits
-
22nd Century Group to Relocate Headquarters to Buffalo’s Thriving Larkinville District
-
The Buffalo News Op-ed: 22nd Century CEO Urges FDA to Proceed with Plan to Limit Nicotine Levels in Cigarettes
-
22nd Century Group (XXII) Announces Federal Court Dismisses Securities Class Action Lawsuit
-
Federal Court Dismisses Securities Class Action Lawsuit Against 22nd Century Group
-
22nd Century Group Expands VLN® Tobacco Growing Program to Support Anticipated Demand of the Company’s Reduced Nicotine Content Cigarettes
-
22nd Century Group (XXII) Achieves Breakthrough Hemp/Cannabis GMO Technology; Granted New Patent for Controlling Genes Responsible for Production of CBD, THC, and Other Valuable Cannabinoids
-
22nd Century Group Achieves Breakthrough Hemp/Cannabis GMO Technology; Granted New Patent for Controlling Genes Responsible for Production of CBD, THC, and Other Valuable Cannabinoids
-
22nd Century (XXII) Receives Order for 3.6 Million New SPECTRUM Variable Nicotine Cigarettes for U.S. Government-Supported Research
-
22nd Century Receives Order for 3.6 Million New SPECTRUM® Variable Nicotine Cigarettes for U.S. Government-Supported Research
-
22nd Century Group to Present at 13th Annual LD Micro Main Event Conference
-
22nd Century’s Vice President of Regulatory Science Publishes Important Public Policy Article
-
22nd Century Group CEO James A. Mish to Speak at Cowen 2020 Boston Cannabis Conference
-
22nd Century Group to Present at the Virtual Fall Investor Summit on November 17
-
22nd Century Group Reports Financial Results and Business Highlights for the Third Quarter 2020
-
22nd Century Group to Host Third Quarter 2020 Webcast and Conduct Quarterly Q&A
-
22nd Century Group to Highlight its Reduced Nicotine Technology at The Food and Drug Law Institute’s Tobacco and Nicotine Products Regulation and Policy Conference
-
22nd Century Group Achieves Breakthrough Technology; Granted New Patent for Reducing Nicotine in Tobacco Plants
-
22nd Century Group Provides Strategy Update Letter from CEO
-
22nd Century Group (XXII) Announces Dr. Michael Koganov to Board
-
22nd Century Appoints Leading Plant Biotechnology Expert Dr. Michael Koganov to Board of Directors
-
22nd Century Group to Present at the LD Micro 500 Virtual Conference
